Stock CGEM CULLINAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
19.25 USD +1.91% Intraday chart for Cullinan Therapeutics, Inc. +6.59% +88.91%
Apr. 16 Transcript : Cullinan Oncology, Inc. - Special Call
Apr. 16 Cullinan Oncology, Inc. Announces Important Updates About Its Plan to Expand into Autoimmune Diseases, the Scientific Rationale for Developing CLN-978 in Autoimmune Diseases CI

Evolution of the average Target Price on Cullinan Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3e3d8f3e6e.iRBwcq0jpfJO9QQdXtlRTqUDuTFMGHsbbCVYJyEr1_I.ziFIPdsOk4M7hl5OMIoAIOFozGYWLRlQX2s8ZXNZur6-eBtG7hDUtT69bw~cc3ce2f1bb82b9190cdc9524de387ad7

Analyst Recommendations on Cullinan Therapeutics, Inc.

CULLINAN ONCOLOGY : Morgan Stanley Adjusts Cullinan Oncology's Price Target to $43 From $40, Maintains Overweight Rating MT
CULLINAN ONCOLOGY : HC Wainwright Adjusts Cullinan Management PT to $55 From $48, Maintains Buy Rating MT
CULLINAN ONCOLOGY : SVB Leerink Adjusts Price Target on Cullinan Management to $54 From $48, Maintains Outperform Rating MT
CULLINAN ONCOLOGY : Morgan Stanley Upgrades Cullinan Management to Overweight from Equalweight, Sets $40 Price Target MT
CULLINAN ONCOLOGY : Morgan Stanley Adjusts Price Target on Cullinan Management to $40 From $38, Maintains Equal-Weight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
19.25 USD
Average target price
28.71 USD
Spread / Average Target
+49.17%
High Price Target
36 USD
Spread / Highest target
+87.01%
Low Price Target
19 USD
Spread / Lowest Target
-1.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cullinan Therapeutics, Inc.

Morgan Stanley
SVB Leerink
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CGEM Stock
  4. Consensus Cullinan Therapeutics, Inc.